Abstract: A method for efficiently sealing the back of photovoltaic modules as part of a repair. The photovoltaic modules pass through several process stages one after another, beginning with a selection of repairable photovoltaic modules, their anonymization and cleaning, followed by further process stages. The further process steps include drying, coating, and treating the coating with pulsed infrared radiation. The process is completed with a check of the process and a functional test using a flash test. The process conditions and apparatus configurations in the process stages are described in detail.

Abstract: A method for checking the functionality of a vibratory conveyor device (1) by means of a status analysis which is carried out either before operation or during operation of the vibratory conveyor device (1), wherein A) the method to be carried out before operation comprises the following steps: A1) applying a drive pulse to a drive device (2) of the vibratory conveyor device (1); A2) detecting the pulse response caused by the vibratory conveyor device (1); A3) passing on the detected pulse response by way of the signal evaluation unit (5) to a computer (6); A4) comparing the detected pulse response to a reference pulse response by means of the computer (6); and A5) ascertaining by means of the computer (6) whether: a) a starting procedure for operation with reduced starting drive power of the vibratory conveyor device (1) is to be activated, or b) a starting procedure for operation without reduced starting drive power of the vibratory conveyor device (1) is to be activated, or c) the operation is to be suspen

Abstract: A process for bioprinting wherein a matrix comprising a modified primary hydroxyl groups containing polysaccharide comprising repeating disaccharide units wherein in at least part of the disaccharide units the primary hydroxyl group is replaced by functional groups selected from carboxyl groups, halide groups or groups comprising sulfur or phosphorus atoms, like e.g. sulfate groups, sulfonate groups, phosphonate groups and phosphate groups, is used and bioink formulations.

Abstract: There are provided systems and methods for automated monitoring of electronic messaging for timed alerts of previously transmitted messages. A sender may transmit an electronic communication to a recipient, where the sender activates an automated timer application to track the viewing and/or response of the communication by the recipient. The application may establish a timer having a set time period of the recipient to respond to the communication. If the recipient fails to respond, view, or otherwise acknowledge the communication by the end of the timer, the application may send an alert to the recipient to remind the recipient of the communication. The recipient and sender may establish preferences for the timer and the alert with the application. Moreover, the application may determine the timer based on the urgency of the communication, as well as determine where and when to send the alert based on recipient information.

Abstract: In a first aspect, the present application relates to a method for producing a tissue model comprising supply structures. In a further aspect, the application relates to tissue models that can he obtained in this way and to the use of said tissue models as models for tissue genesis, in particular tumorigenesis, including angiogenesis, in the tissue model. Finally, a method for testing and identifying active ingredient candidates, including treatment strategies, is provided.

Abstract: An implant 1 comprising an enossal area 3 and provided with a coating 2, wherein the coating 2 at least partially covers the enossal area 3, and the coating 2 facilitates the ongrowth of the implant 1 within the bone, characterized in that said coating can be removed chemically and/or mechanically under physiological condition.

Abstract: A process for producing three-dimensional shaped ceramic bodies by layerwise printing of a suspension comprising the constituents required for formation of the shaped ceramic bodies by means of an inkjet printer in the desired two-dimensional shape onto a support material, drying and hardening of the layer composite formed, which is characterized in that printing is effected using a suspension comprising from 50 to 80% by weight of ceramic particles in a dispersion medium comprising an aqueous boehmite sol, at least one low molecular weight alcohol, at least one drying inhibitor and at least one organic fluidizer, and also an apparatus for carrying out this process are described.

Abstract: Compositions and methods for therapy of cystic fibrosis, asthma, and other conditions characterized by defective chloride transport are provided. The compositions comprise one or more compounds such as flavones and/or isoflavones, ascorbate and/or derivatives thereof capable of stimulating chloride transport in epithelial tissues. Therapeutic methods involve the administration (e.g., orally or via inhalation) of such compositions to a patient afflicted with cystic fibrosis, asthma, and/or another condition responsive to stimulation of chloride transport.

Abstract: The invention relates to polymer mixtures comprising at least one polymer, at least one organic halogenated compound such as halogenated flame retardants and also at least one further compound to thermally stabilize the organic halogenated compound, this further compound having a saponification number of 80 to 300 mg KOH/g and an OH number of 200 to 800 mg KOH/g.

Abstract: Compositions and methods for therapy of cystic fibrosis, asthma, and other conditions characterized by defective chloride transport are provided. The compositions comprise one or more compounds such as flavones and/or isoflavones, ascorbate and/or derivatives thereof capable of stimulating chloride transport in epithelial tissues. Therapeutic methods involve the administration (e.g., orally or via inhalation) of such compositions to a patient afflicted with cystic fibrosis, asthma, and/or another condition responsive to stimulation of chloride transport.

Abstract: Compositions and methods for therapy of cystic fibrosis, asthma, and other conditions characterized by defective chloride transport are provided. The compositions comprise one or more compounds such as flavones and/or isoflavones, ascorbate and/or derivatives thereof capable of stimulating chloride transport in epithelial tissues. Therapeutic methods involve the administration (e.g., orally or via inhalation) of such compositions to a patient afflicted with cystic fibrosis, asthma, and/or another condition responsive to stimulation of chloride transport.

Abstract: A process for producing three-dimensional shaped ceramic bodies by layerwise printing of a suspension comprising the constituents required for formation of the shaped ceramic bodies by means of an inkjet printer in the desired two-dimensional shape onto a support material, drying and hardening of the layer composite formed, which is characterized in that printing is effected using a suspension comprising from 50 to 80% by weight of ceramic particles in a dispersion medium comprising an aqueous boehmite sol, at least one low molecular weight alcohol, at least one drying inhibitor and at least one organic fluidizer, and also an apparatus for carrying out this process are described.

Abstract: The present invention relates to a bi-material radio frequency transmission line of cylindrical shape comprising a thin layer of highly conductive material supported by a base material wherein both materials are selected in function of the frequency of the transmitted signal and wherein the thickness of the thin layer is in a range from 1.2 to 2.4 times the depth of the skin effect at the frequency corresponding to the transmitted signal.

Abstract: The invention relates to a developer device for designing a control system comprising automation software and automation hardware for the automatic operation of a process. The designing device comprises a design module which is embodied in order to design the automatic software, an engineering module which is connected to the design module in order to receive the automation software, and which is configured in order to project the automation hardware based on the automation software and to produce projection data on the automation hardware, and a simulation module for simulating the automation software and the processes, and which is connected to the engineering module which is used to receive the projection data, in addition to the design module which is used to transfer simulated process data.

Abstract: Compositions and methods for therapy of cystic fibrosis and other conditions are provided. The compositions comprise one or more compounds such as flavones and/or isoflavones capable of stimulating chloride transport in epithelial tissues. Therapeutic methods involve the administration (e.g., orally or via inhalation) of such compositions to a patient afflicted with cystic fibrosis and/or another condition responsive to stimulation of chloride transport.

Abstract: Method and apparatus for creating and checking a circuit diagram for a circuit which is to be integrated. On the basis of this circuit diagram, a layout for the circuit which is to be integrated is designed. Both when designing the circuit diagram and in a layout description extracted from the designed layout, the sections of connecting lines within the line networks are defined by structure parameter values which prescribe the length and width of the line sections and also specify the impedance-determining layer properties of the conductor layer which is to be produced when integrating the respective line section. Individual line networks in the layout are then compared with the corresponding networks in the circuit diagram by comparing the indicated structure parameter values.

Abstract: Compositions and methods for therapy of cystic fibrosis, asthma, and other conditions characterized by defective chloride transport are provided. The compositions comprise one or more compounds such as flavones and/or isoflavones, ascorbate and/or derivatives thereof capable of stimulating chloride transport in epithelial tissues. Therapeutic methods involve the administration (e.g., orally or via inhalation) of such compositions to a patient afflicted with cystic fibrosis, asthma, and/or another condition responsive to stimulation of chloride transport.

Abstract: A cleaned, sterile ceramic, metallic or polymeric substrate surface is vapor-deposited under sterile conditions with silica, is wetted on top of this with a saline coupling agent under sterile conditions, and is provided on top of the latter with a preserving protective layer which is sterile and/or can be sterilized after polymerization and constitutes the activatable first component of a multi-component adhesive which at the time of use is formed by addition of at least one further adhesive component. A workpiece which has been partially or completely coated in this way can be connected with good adhesion to a polymer, even after several months of sterile storage and transportation, by means of the activation of the protective layer with a monomer.

Abstract: Compositions and methods for therapy of cystic fibrosis and other conditions are provided. The compositions comprise one or more compounds such as flavones and/or isoflavones capable of stimulating chloride transport in epithelial tissues. Therapeutic methods involve the administration (e.g., orally or via inhalation) of such compositions to a patient afflicted with cystic fibrosis and/or another condition responsive to stimulation of chloride transport.

Abstract: A coaxial high-frequency cable is described which having an inner conductor (1), a dielectric spacer (2) surrounding the inner conductor (1), and a tubular outer conductor (3) which is applied over the dielectric (2) and which is concentric with the inner conductor (1). To ensure operability in the event of a fire, the spacer is constructed from a combination of an insulating thermoplastic material and a mineral material.